Stay updated with breaking news from Ossdsign Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, SWEDEN, September 27, 2023. Karolinska Development AB announces that its portfolio company OssDsign successfully has completed a directed share issue to a value of approximately SEK 150...
STOCKHOLM, SWEDEN, September 19, 2023. Karolinska Development AB announces that its portfolio company OssDsign has received clearance from FDA for the use of OssDsign Catalyst in interbody cages in...
04.01.2023 - STOCKHOLM, SWEDEN, January 4, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has published the first case report on a patient that underwent spinal fusion surgery with OssDsign Catalyst in the ...
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled all patients in the clinical study TOP FUSION, which